Coronavirus
In the context of supply issues, the African Union has abandoned plans to procure coronavirus vaccines from the Serum Institute in India and is now discussing possibilities with the U.S. Johnson & Johnson.
John Nkengasong, head of the African Disease Control Centers, said the sufficient supply of vaccine was crucial – and that export constraints by India is problematic for Africa.
He went on to say that the AU's decision had nothing to do with the potential connection to blood clots in some rare cases surrounding the Oxford-AstraZeneca vaccine.
He stressed that the AstraZeneca vaccine will still be distributed to Africa through the UN's Covax program.
Nkengasong claimed that the AU had already signed a contract with Johnson & Johnson for up to 400 million single dose vaccines.
01:03
Ebola: DRC receives shipment of more than 16,000 vaccine doses
00:59
DRC Ebola outbreak growing 'exponentially,' UN warns, as deaths exceed 2,500
01:14
DR Congo receives 70,000 Ebola vaccine doses for outbreak response
00:52
US national debt tops 40 trillion dollars for first time
00:48
First person vaccinated during trial of new Ebola jab
02:06
Equatorial Guinea and Gabon resolve 50-year border dispute